Pfizer Inc. (PFE)
NYSE: PFE · IEX Real-Time Price · USD
28.66
+0.46 (1.63%)
At close: May 31, 2024, 4:00 PM
28.74
+0.08 (0.28%)
After-hours: May 31, 2024, 7:59 PM EDT
Pfizer Revenue
Pfizer had revenue of $55.09B in the twelve months ending March 31, 2024, down -40.86% year-over-year. Revenue in the quarter ending March 31, 2024 was $14.88B, a -19.51% decrease year-over-year. In the year 2023, Pfizer had annual revenue of $58.50B, a decrease of -41.70%.
Revenue (ttm)
$55.09B
Revenue Growth
-40.86%
P/S Ratio
2.95
Revenue / Employee
$626,068
Employees
88,000
Market Cap
162.40B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 58.50B | -41.83B | -41.70% |
Dec 31, 2022 | 100.33B | 19.04B | 23.43% |
Dec 31, 2021 | 81.29B | 39.64B | 95.16% |
Dec 31, 2020 | 41.65B | 746.00M | 1.82% |
Dec 31, 2019 | 40.91B | 80.00M | 0.20% |
Dec 31, 2018 | 40.83B | -11.72B | -22.31% |
Dec 31, 2017 | 52.55B | -278.00M | -0.53% |
Dec 31, 2016 | 52.82B | 3.97B | 8.13% |
Dec 31, 2015 | 48.85B | -754.00M | -1.52% |
Dec 31, 2014 | 49.61B | -1.98B | -3.84% |
Dec 31, 2013 | 51.58B | -3.07B | -5.62% |
Dec 31, 2012 | 54.66B | -6.38B | -10.45% |
Dec 31, 2011 | 61.04B | -4.13B | -6.34% |
Dec 31, 2010 | 65.17B | 15.90B | 32.26% |
Dec 31, 2009 | 49.27B | 973.00M | 2.01% |
Dec 31, 2008 | 48.30B | -122.00M | -0.25% |
Dec 31, 2007 | 48.42B | 47.00M | 0.10% |
Dec 31, 2006 | 48.37B | 966.00M | 2.04% |
Dec 31, 2005 | 47.41B | -1.58B | -3.23% |
Dec 31, 2004 | 48.99B | 4.25B | 9.50% |
Dec 31, 2003 | 44.74B | 12.44B | 38.53% |
Dec 31, 2002 | 32.29B | 3.27B | 11.27% |
Dec 31, 2001 | 29.02B | 2.98B | 11.44% |
Dec 31, 2000 | 26.05B | -1.12B | -4.13% |
Dec 31, 1999 | 27.17B | 3.94B | 16.94% |
Dec 31, 1998 | 23.23B | 12.18B | 110.14% |
Dec 31, 1997 | 11.06B | 1.19B | 12.07% |
Dec 31, 1996 | 9.86B | -157.00M | -1.57% |
Dec 31, 1995 | 10.02B | 2.04B | 25.62% |
Dec 31, 1994 | 7.98B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Elevance Health | 171.75B |
Sanofi | 51.60B |
Novartis AG | 49.92B |
Thermo Fisher | 42.49B |
Abbott Laboratories | 40.33B |
Amgen | 29.53B |
Danaher | 22.52B |
Stryker | 20.96B |
PFE News
- 7 hours ago - Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data - Fox Business
- 17 hours ago - Pfizer's drug for advanced lung cancer shows promising long-term trial results - CNBC
- 18 hours ago - Pfizer's LORBRENA® CROWN Study Shows Majority of Patients with ALK-Positive Advanced Lung Cancer Living Beyond Five Years Without Disease Progression - Business Wire
- 19 hours ago - EU regulator recommends use of Pfizer's gene therapy for rare bleeding disorder - Reuters
- 1 day ago - New U.S. bird-flu case is first with respiratory symptoms, CDC says - Market Watch
- 1 day ago - Healthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conference - CNBC
- 9 days ago - Pfizer aims to save $1.5 billion by 2027 in first wave of new cost cuts - CNBC
- 9 days ago - Pfizer to Cut Costs in Multi-Year Effort - WSJ